Market Forecast By Product Type (Type A, Type B), By Application (Aesthetic, Therapeutic), By End User (Hospitals, Dermatology & Aesthetic Clinics, Others (Rehabilitation Centers, Research Institutes, Etc.)) And Competitive Landscape
Product Code: ETC9680003 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 18 | No. of Tables: 4 | |
Thailand Botulinum Toxin Market Report thoroughly covers the market By Product Type, By Application and By end user. Thailand Botulinum Toxin Market Outlook report provides an unbiased and detailed analysis of the ongoing Thailand Botulinum Toxin Market trends, opportunities/high growth areas, and market drivers. This would help stakeholders devise and align their market strategies according to the current and future market dynamics.
Thailand's Botulinum Toxin market is witnessing significant growth, primarily driven by booming medical tourism and the rising demand for medical aesthetics. The country attracts over 25 million international visitors annually, offers cost savings compared to Western nations while maintaining high standards of safety and quality. Thailand ranks 4th in Asia (after South Korea, Japan, and China) in medical aesthetic tourism revenue, according to Siam Commercial Bank. The Thailand Medical Hub Board projects that the medical aesthetics market would grow more by 2027. Supporting this expansion, Thailand has a well-established network for aesthetic clinics.
According to 6Wresearch, Thailand Botulinum Toxin Market revenue is projected to grow at a CAGR of 6.4% during 2025-2031. Thailand’s healthcare and cosmetic industries are poised for substantial growth, driven by increasing demand and strategic investments. The healthcare sector is on a strong growth trajectory, with total spending projected to surpass USD 32 billion by 2026, driven by a 7.35% CAGR from 2023 to 2026. A major contributor to this expansion is the booming medical tourism industry, which has been growing at an 11.6% CAGR from 2019 to 2027 and is expected to reach USD 9.9 billion by 2027. Under the 20-Year National Strategy (2018–2037), Yuthasak anticipates millions medical tourists will contribute 200 billion baht to Thailand’s economy by 2037. Meanwhile, Thailand’s cosmetic industry is also experiencing rapid expansion, with projected growth of 9.5%–10% in 2024 and up to 11% in 2025. By 2030, the market is expected to exceed USD 10 billion, maintaining a steady annual growth rate of 5.0% since 2022.
In 2031, Type A is expected to witness the highest growth, primarily due to its widespread use in reducing facial wrinkles and fine lines. This surge is attributed to increasing beauty consciousness and the growing preference for minimally invasive treatments. Additionally, Type A is utilized in treating various medical conditions such as chronic migraines, muscle spasticity, and overactive bladder.
In 2031, the Aesthetic Application segment is expected to experience the highest growth, driven by the increasing focus on youthful appearance and cosmetic enhancements, which is fueling demand for botulinum toxin procedures. Additionally, Thailand's status as a hub for medical tourism, with a growing influx of international clients seeking affordable, high-quality aesthetic treatments, is further boosting market expansion.
In 2031, the Dermatology & Aesthetic Clinics segment is expected to grow at a faster rate, as these clinics offer specialized and personalized treatments tailored to individual needs, setting them apart from general hospitals. Moreover, there is a growing trend among individuals seeking non-invasive and minimally invasive aesthetic treatments, such as botulinum toxin injections, to enhance their appearance.
The report provides a detailed analysis of the following market segments:
1. Executive Summary |
2. Introduction |
2.1. Key Highlights of the Report |
2.2. Report Description |
2.3. Market Scope & Segmentation |
2.4. Research Methodology |
2.5. Assumptions |
3. Thailand Botulinum Toxin Market Overview |
3.1. Thailand Botulinum Toxin Market Revenues and Revenue Share, 2021-2031F |
3.2. Thailand Botulinum Toxin Market Industry Life Cycle |
3.3. Thailand Botulinum Toxin Market Porter's Five Forces |
4. Thailand Botulinum Toxin Market Dynamics |
4.1. Impact Analysis |
4.2. Market Drivers |
4.3. Market Restraints |
5. Thailand Botulinum Toxin Market Trends And Evolution |
6. Thailand Botulinum Toxin Market Overview, By Product Type |
6.1. Thailand Botulinum Toxin Market Revenue Share, By Product Type, 2024 & 2031F |
6.1.1. Thailand Botulinum Toxin Market Revenues, By Type A, 2021-2031F |
6.1.2. Thailand Botulinum Toxin Market Revenues, By Type B, 2021-2031F |
7. Thailand Botulinum Toxin Market Overview, By Application |
7.1. Thailand Botulinum Toxin Market Revenue Share, By Application, 2024 & 2031F |
7.1.1. Thailand Botulinum Toxin Market Revenues, By Aesthetic Applications, 2021-2031F |
7.1.2. Thailand Botulinum Toxin Market Revenues, By Therapeutic Applications, 2021-2031F |
8. Thailand Botulinum Toxin Market Overview, By End User |
8.1. Thailand Botulinum Toxin Market Revenue Share, By End User, 2024 & 2031F |
8.1.1. Thailand Botulinum Toxin Market Revenues, By Hospitals, 2021-2031F |
8.1.2. Thailand Botulinum Toxin Market Revenues, By Dermatology & Aesthetic Clinics, 2021-2031F |
8.1.3. Thailand Botulinum Toxin Market Revenues, By Others, 2021-2031F |
9. Thailand Botulinum Toxin Market Key Performance Indicator |
10. Thailand Botulinum Toxin Market Opportunity Assessment |
10.1. Thailand Botulinum Toxin Market Opportunity Assessment, By Product Type, 2031F |
10.2. Thailand Botulinum Toxin Market Opportunity Assessment, By Application, 2031F |
10.3. Thailand Botulinum Toxin Market Opportunity Assessment, By End User, 2031F |
11. Thailand Botulinum Toxin Market Competitive Landscape |
11.1 Thailand Botulinum Toxin Market Revenue Ranking, By Top 3 Companies, 2024 |
11.2 Thailand Botulinum Toxin Market Competitive Benchmarking, By Operating Parameters |
12. Company Profiles |
12.1 Merz Pharma GmbH & Co. |
12.2 Medy-Tox, Inc. |
12.3 Hugel inc |
12.4 Galderma |
12.5 AbbVie Inc (Allergan plc) |
12.6 Ipsen Pharma |
12.7 Daewoong Pharmaceutical |
12.8 Evolus Inc |
12.9 BNC Korea |
12.10 Supernus Pharmaceuticals, Inc. |
13. Key Strategic Recommendations |
14. Disclaimer |
list of figures |
1. Thailand Botulinum Toxin Market Revenues, 2021-2031F (Million USD) |
2. Thailand's : International patients in Thailand 2021-2024, (Million USD) |
3. Thailand Medical Tourism Market Size, USD Million, 2022-2026F |
4. Thailand Total Number Of Procedures, By Type, 2023 (%) |
5. Thailand Medical Aesthetic Market Size, 2020 & 2027 (Billion USD) |
6. Thailand Botulinum Toxin Market , By Product Type, 2024 & 2031F |
7. Thailand Botulinum Toxin Market Revenue Share, By Application, 2024 & 2031F |
8. Thailand Botulinum Toxin Market Revenue Share, By End User, 2024 & 2031F |
9. Thailand Common Procedures, 2023 (%) |
10. Thailand Injectables Procedures, 2023 |
11. Thailand Facial Rejuvenation Procedures (2023) |
12. Thailand Spending Healthcare Market, 2022-2026F ($ Billion) |
13. Thailand’s Healthcare Facilities, 2023 |
14. Thailand's 60+ Population Projection (2020-2050) |
15. Thailand Botulinum Toxin Market Opportunity Assessment, By Product Type, 2031F (USD Million) |
16. Thailand Botulinum Toxin Market Opportunity Assessment, By Application, 2031F (USD Million) |
17. Thailand Botulinum Toxin Market Opportunity Assessment, By End User, 2031F (USD Million) |
18. Thailand Botulinum Toxin Market, Revenue Ranking, 2024 |
list of tables |
1. Thailand Botulinum Toxin Market Revenue, By Product Type, 2021-2031F (USD Million) |
2. Thailand Botulinum Toxin Market Revenue, By Application, 2021-2031F (USD Million) |
3. Thailand Botulinum Toxin Market Revenue, By End User, 2021-2031F (USD Million) |
4. Thailand Skin Clinics 2023 |